These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 15565914

  • 1. Antifungal activity of amphotericin B and itraconazole against filamentous fungi: comparison of the Sensititre Yeast One and NCCLS M38--a reference methods.
    Carrillo-Muñoz AJ, Quindós G, Del Valle O, Hernández-Molina JM, Santos P.
    J Chemother; 2004 Oct; 16(5):468-73. PubMed ID: 15565914
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.
    Espinel-Ingroff A.
    J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057
    [Abstract] [Full Text] [Related]

  • 3. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J, Peláez T, Alcalá L, Bouza E.
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):53-5. PubMed ID: 16650953
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J, Mouton JW, Meis JF, Bouman BA, Verweij PE.
    J Clin Microbiol; 2002 Aug; 40(8):2876-85. PubMed ID: 12149345
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E, Pemán J, Valverde A, Chaves M, Serrano MC, Cantón E.
    J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
    [Abstract] [Full Text] [Related]

  • 6. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A.
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [Abstract] [Full Text] [Related]

  • 7. In vitro antifungal susceptibility testing of filamentous fungi with Sensititre Yeast One.
    Carrillo-Muñoz AJ, Quindós G, Ruesga M, del Valle O, Pemán J, Cantón E, Hernández-Molina JM, Santos P.
    Mycoses; 2006 Jul; 49(4):293-7. PubMed ID: 16784443
    [Abstract] [Full Text] [Related]

  • 8. In vitro testing of Aspergillus fumigatus clinical isolates for susceptibility to voriconazole, amphotericin B and itraconazole: comparison of sensititre versus NCCLS M38-A using two different inocula.
    Drago M, Scaltrito MM, Cariani L, Morace G.
    J Chemother; 2004 Oct; 16(5):474-8. PubMed ID: 15565915
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC, Hsieh MI, Choi PC, Wu CJ.
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
    [Abstract] [Full Text] [Related]

  • 10. In vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosis.
    Hennequin C, Benailly N, Silly C, Sorin M, Scheinmann P, Lenoir G, Gaillard JL, Berche P.
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2064-6. PubMed ID: 9303420
    [Abstract] [Full Text] [Related]

  • 11. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Lewis RE, Wiederhold NP, Klepser ME.
    Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
    Bernal S, Aller AI, Chávez M, Valverde A, Serrano C, Gutiérrez MJ, Quindós G, Martín Mazuelos E.
    Chemotherapy; 2002 Mar; 48(1):21-5. PubMed ID: 11901252
    [Abstract] [Full Text] [Related]

  • 13. In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species.
    Kantarcioğlu AS, Yucel A.
    J Chemother; 2002 Dec; 14(6):562-7. PubMed ID: 12583546
    [Abstract] [Full Text] [Related]

  • 14. [Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method].
    Carrillo-Muñoz AJ, Quindós G, Ruesga M, Brió S, del Valle O, Rodríguez V, Hernández-Molina JM, Cantón E, Pemán J, Santos P.
    Rev Esp Quimioter; 2001 Sep; 14(3):281-5. PubMed ID: 11753450
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
    Morace G, Drago M, Scaltrito MM, Conti S, Fanti F, Polonelli L, GISIA Participants Group.
    J Chemother; 2007 Oct; 19(5):508-13. PubMed ID: 18073149
    [Abstract] [Full Text] [Related]

  • 16. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
    Guinea J, Peláez T, Alcalá L, Bouza E.
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3):273-6. PubMed ID: 17141455
    [Abstract] [Full Text] [Related]

  • 17. Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.
    Dannaoui E, Persat F, Monier MF, Borel E, Piens MA, Picot S.
    Can J Microbiol; 1999 Oct; 45(10):871-4. PubMed ID: 10907424
    [Abstract] [Full Text] [Related]

  • 18. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J, Mouton JW, Meis JF, Bouman BA, Donnelly PJ, Verweij PE, EUROFUNG Network.
    J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD, Kiraz N.
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [Abstract] [Full Text] [Related]

  • 20. Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method.
    Meletiadis J, Meis JF, Mouton JW, Donnelly JP, Verweij PE.
    J Clin Microbiol; 2000 Aug; 38(8):2949-54. PubMed ID: 10921957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.